An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality.
about
Identifying postoperative atrial fibrillation in cardiac surgical patients posthospital discharge, using iPhone ECG: a study protocol.Hemoglobin A1c and risk of left atrial thrombus and spontaneous echo contrast in non-valvular atrial fibrillation patientsPatient perspective on the management of atrial fibrillation in five European countries.Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012Stroke Prevention in Atrial Fibrillation: Where are We Now?Atrial fibrillation: its prevalence and risk factor profile in the German general population.Screening Education And Recognition in Community pHarmacies of Atrial Fibrillation to prevent stroke in an ambulant population aged >=65 years (SEARCH-AF stroke prevention study): a cross-sectional study protocolStroke prevention in atrial fibrillation: concepts and controversiesReproducibility and Reliability of the Quality of Life Questionnaire in Patients With Atrial Fibrillation.Patient preferences at ten years following initial diagnosis of atrial fibrillation: the Belgrade Atrial Fibrillation Study.Demographic Characteristics and Patterns of Medication in Atrial Fibrillation Patients in South West Ontario: Insights from a Large Primary Care Database.Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis.Is bleeding a necessary evil? The inherent risk of antithrombotic pharmacotherapy used for stroke prevention in atrial fibrillation.Disease understanding in patients newly diagnosed with atrial fibrillation.Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation.Factors Affecting Patients' Perception On, and Adherence To, Anticoagulant Therapy: Anticipating the Role of Direct Oral Anticoagulants.'What else can I do?': Insights from atrial fibrillation patient communication online.Predictive factors for obtaining a correct therapeutic range using antivitamin K anticoagulants: a tertiary center experience of patient adherence to anticoagulant therapy.How are patients with atrial fibrillation approached and informed about their risk profile and available therapies in Europe? Results of the European Heart Rhythm Association Survey.Health Literacy and Atrial Fibrillation: Relevance and Future Directions for Patient-centred Care.Association between subjective risk perception and objective risk estimation in patients with atrial fibrillation: a cross-sectional study.Building Atrial Fibrillation Awareness: Is it Time to get Beyond the Top Line?Patients' experiences from symptom onset to initial treatment for atrial fibrillation.A proposal for interdisciplinary, nurse-coordinated atrial fibrillation expert programmes as a way to structure daily practice.Content and distribution of discursive space in consultations between patients with atrial fibrillation and healthcare professionals.Are Older Adults Willing to Consider New Strategies to Reduce Stroke Risk?Oral anticoagulation in patients with atrial fibrillation and medical non-neoplastic disease in a terminal stage.Perception paradox between the doctors and patients in the industrial-bureaucratic age of medicine: Defensive versus offensive medicine in anticoagulation and atrial fibrillation ablation.Oral Anticoagulation in Atrial Fibrillation: Development and Evaluation of a Mobile Health Application to Support Shared Decision-Making.Patients' experiences of communication and involvement in decision-making about atrial fibrillation treatment in consultations with nurses and physicians.Knowledge of Atrial Fibrillation and Stroke Prevention: Development of Questionnaire and Validation of Results.
P2860
Q30616300-525CCEAE-422F-4FC4-8053-D907635CE834Q33592535-E92A3768-3DAD-40DE-8D2C-B6428E2C2D6DQ34448536-015E8C15-6C98-4C39-9138-18DEE88EA3EBQ34725585-1BD2BF63-C5D0-4FD2-ACE9-5B11966BD3CAQ35811581-C2EA5E1C-DEA7-48ED-9D7D-670CA29ED7C3Q35949669-91DE4974-3FE7-4823-A171-351C6F40C348Q36060854-B55A720D-80B9-4C41-B728-28D9A640E952Q36382375-380067E1-69F4-4651-B19F-4FC44838414BQ36738217-73CA89C3-5B72-4F21-827B-B4483397E405Q37134738-6960C898-B014-4609-934E-CC6752EC1186Q37496201-DA803C5E-4291-4114-92B6-8BBB450FB4ECQ37868373-79494585-AFED-4094-A06C-9D3FCCD0164EQ38132255-84BB537A-8450-497E-BBB9-452DC19ABA10Q38372509-06C131F5-7479-4E62-B987-7D4086D72728Q38372780-5549E981-170A-4B9C-8448-9693910495E3Q38903357-099BD60E-68BC-496C-9775-E26B792A4A50Q38940342-E571A735-6276-4CA9-82DB-A67478BB9DCFQ40520350-902333E3-99DF-4BCA-8B94-34CCC305E2C5Q41342570-A9C76146-AC2E-4BEB-85FA-E61DCA088AA2Q41720527-767281E1-2320-4789-A4F5-21892A4CD56FQ42110922-5532D60A-48C8-43A0-AD6A-6D37BD22CDDFQ42353692-BB7F6900-EED9-4AE1-A683-8D1DD55FA094Q42694656-62AAF548-ABC3-4EBD-9BD8-4CA28C833497Q43449633-12DF66CD-E312-4B35-9039-D33C749A80B7Q45913748-ABDABB2A-7D6D-423B-82AB-A4A8A3EB443DQ47911720-AE4D1BB9-0C03-4F7D-8064-59E9847F6429Q48116623-88DBF987-A9E4-486E-B141-6C5A6966A54BQ48353520-A61A0EA7-462D-4BFB-9D5A-D691885ECE05Q50142620-16361B48-8ECB-43FF-BBCE-E76742BC0ECBQ50247484-BAF9BE33-6FF6-4665-9B87-D1F23598E680Q55276537-D92CE748-17D1-4CB5-B05D-DF2E2EC76235
P2860
An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
An international survey of phy ...... sease morbidity and mortality.
@ast
An international survey of phy ...... sease morbidity and mortality.
@en
type
label
An international survey of phy ...... sease morbidity and mortality.
@ast
An international survey of phy ...... sease morbidity and mortality.
@en
prefLabel
An international survey of phy ...... sease morbidity and mortality.
@ast
An international survey of phy ...... sease morbidity and mortality.
@en
P2093
P2860
P50
P921
P356
P1433
P1476
An international survey of phy ...... sease morbidity and mortality.
@en
P2093
Atrial Fibrillation AWareness And Risk Education group
Atrial Fibrillation Association
Etienne Aliot
Josep Brugada
Markus Wagner
Panos E Vardas
Stroke Alliance for Europe
World Heart Federation
P2860
P304
P356
10.1093/EUROPACE/EUQ109
P577
2010-05-01T00:00:00Z